Home Expanded access programs

Expanded access programs

Expanded access programs (EAPs) in the U.S., named patient programs (NPPs) in Europe, and special access schemes (SASs) in Australia allow continued access to investigational products outside of a clinical trial for patients for whom there are no comparable or satisfactory alternate options.

Compassionate use

Telix is often contacted to provide access to our products under compassionate use. We respect the treatment journey of the patient and the independence of healthcare professionals in making their treatment decisions. Telix tries to accommodate such requests whenever it is clinically, ethically and practically feasible to do so.

You can find Telix’s compassionate use policy here:

Policy on Offering Compassionate Use to Investigational Medicines

Request form

    Private Information

    In order to handle an enquiry, we are required to record and maintain the data and personal information about patients that have been provided to us. This may include name and contact details, and eventually patient information, such as initials and medical need summary. The personal information will be processed for the purposes of dealing with enquiries, complying with applicable laws and related internal records keeping purposes. For more information, please consult our Privacy Notice.